During the past decade, Quest Research Institute conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 40 clinical trials were completed, i.e. on average, 63.5% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 24 clinical trials were completed. i.e. 96% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Quest Research Institute" #1 sponsor was "Impax Laboratories, LLC" with 10 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "Biogen" with 4 trials sponsored and "Eli Lilly and Company" with 4 trials sponsored. Other sponsors include 68 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Quest Research Institute" #1 collaborator was "Michael J. Fox Foundation for Parkinson's Research" with 2 trials as a collaborator, "Prothena Biosciences Limited" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator, "Denali Therapeutics Inc." with 1 trials as a collaborator and "Duke University" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Quest Research Institute" are "Parkinson's Disease" (25 trials), "Parkinson Disease" (16 trials), "Alzheimer Disease" (5 trials), "Osteoarthritis" (4 trials) and "Alzheimer's Disease" (3 trials). Many other conditions were trialed in "Quest Research Institute" in a lesser frequency.

Most popular intervention types in "Quest Research Institute" are "Drug" (91 trials), "Other" (9 trials), "Biological" (5 trials), "Device" (3 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (46 trials), "APL-130277" (4 trials), "placebo" (3 trials), "Accordion Pill™ Carbidopa/Levodopa" (2 trials) and "CD-LD IR" (2 trials). Other intervention names were less common.

The vast majority of trials in "Quest Research Institute" are 98 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Quest Research Institute". undefined are not yet recruiting, 10 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 68 completed trials in Quest Research Institute, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Quest Research Institute, 13 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".